Biggest changeAs of, and for the year ended, December 31, 2024 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Bioenergy Eliminations Total Reportable Segments Corporate & Other Total Bunge Consolidated Net sales to external customers $ 38,598 $ 12,771 $ 1,555 $ 130 $ — $ 53,054 $ 54 $ 53,108 Inter–segment revenues 7,299 251 85 — (7,635) — — — Raw materials cost (34,978) (10,582) (1,096) (127) — (46,783) (34) (46,817) Industrial expenses- fixed (941) (542) (171) — — (1,654) (22) (1,676) Industrial expenses- variable (522) (226) (38) — — (786) (4) (790) Depreciation (243) (134) (32) — — (409) (23) (432) Cost of goods sold (36,684) (11,484) (1,337) (127) — (49,632) (83) (49,715) Selling, general and administrative expenses (603) (416) (97) (2) — (1,118) (658) (1,776) Foreign exchange (losses) gains – net (171) (20) (3) — — (194) 5 (189) EBIT - Noncontrolling interests (1) (9) (35) — — — (44) 4 (40) Other income (expense) – net 226 (57) (6) 196 — 359 83 442 (Loss) income from affiliates (56) — (1) 18 — (39) 1 (38) EBIT (2) 1,301 759 111 215 — 2,386 (594) 1,792 Total depreciation, depletion and amortization (243) (167) (35) — — (445) (23) (468) Total assets 14,961 4,145 914 130 — 20,150 4,749 24,899 Capital expenditures 763 340 44 — — 1,147 229 1,376 F-66 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) As of, and for the year ended, December 31, 2023 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Bioenergy Eliminations Total Reportable Segments Corporate & Other Total Bunge Consolidated Net sales to external customers $ 42,764 $ 14,603 $ 1,896 $ 235 $ — $ 59,498 $ 42 $ 59,540 Inter–segment revenues 8,360 176 175 — (8,711) — — — Raw materials cost (37,695) (12,346) (1,494) (229) — (51,764) (5) (51,769) Industrial expenses- fixed (950) (511) (161) — — (1,622) (29) (1,651) Industrial expenses- variable (581) (254) (43) — — (878) (4) (882) Depreciation (217) (123) (31) — — (371) (22) (393) Cost of goods sold (39,443) (13,234) (1,729) (229) — (54,635) (60) (54,695) Selling, general and administrative expenses (592) (425) (95) (1) — (1,113) (602) (1,715) Foreign exchange gains – net — 7 1 — — 8 12 20 EBIT - Noncontrolling interests (1) (70) (21) 1 — — (90) 4 (86) Other income (expense) – net 126 (65) (7) 2 — 56 73 129 Income (loss) from affiliates 1 — (1) 157 — 157 (17) 140 EBIT (3) 2,786 865 66 164 — 3,881 (548) 3,333 Depreciation, depletion and amortization (217) (179) (33) — — (429) (22) (451) Total assets 16,000 3,969 984 471 — 21,424 3,948 25,372 Capital expenditures 551 429 45 — — 1,025 97 1,122 As of, and for the year ended, December 31, 2022 (US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and Bioenergy Eliminations Total Reportable Segments Corporate & Other Total Bunge Consolidated Net sales to external customers $ 47,700 $ 16,850 $ 2,388 $ 259 $ — $ 67,197 $ 35 $ 67,232 Inter–segment revenues 10,200 306 564 — (11,070) — — — Raw materials cost (43,715) (14,784) (1,884) (250) — (60,633) (20) (60,653) Industrial expenses- fixed (844) (531) (166) — — (1,541) (21) (1,562) Industrial expenses- variable (649) (266) (48) — — (963) (3) (966) Depreciation (202) (111) (30) — — (343) (26) (369) Cost of goods sold (45,410) (15,692) (2,128) (250) — (63,480) (70) (63,550) Selling, general and administrative expenses (532) (357) (102) (1) — (992) (377) (1,369) Foreign exchange gains (losses) – net 2 (14) 4 2 — (6) (5) (11) EBIT - Noncontrolling interests (1) (45) (12) (1) — — (58) (9) (67) Other (expense) income – net (67) (29) 1 2 — (93) 84 (9) Income (loss) from affiliates 67 — — 93 — 160 (55) 105 EBIT (4) 1,715 746 162 105 — 2,728 (397) 2,331 Depreciation, depletion and amortization (203) (146) (32) — — (381) (27) (408) Total assets 16,486 3,886 1,195 334 — 21,901 2,679 24,580 Capital expenditures 312 169 30 — — 511 44 555 F-67 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) (1) Includes Net (income) attributable to noncontrolling interests and redeemable noncontrolling interests adjusted for noncontrolling interests' share of interest and taxes.
Biggest changeThe segment revenues generated from these transfers are shown in the following table as "Inter-segment revenues." F-71 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) As of, and for the year ended, December 31, 2025 (US$ in millions) Soybean Processing and Refining Softseed Processing and Refining Other Oilseeds Processing and Refining Grain Merchandising and Milling Eliminations Total Reportable Segments Corporate & Other Total Bunge Consolidated Net sales to external customers $ 36,313 $ 11,252 $ 4,633 $ 18,128 $ — $ 70,326 $ 3 $ 70,329 Inter–segment revenues 661 1,442 335 1,796 (4,234) — — Raw materials cost (32,852) (9,844) (3,786) (16,856) — 12 (63,326) Industrial expenses- fixed (925) (387) (287) (432) — (6) (2,037) Industrial expenses- variable (507) (219) (105) (69) — — (900) Depreciation (264) (125) (78) (163) — (27) (657) Selling, general and administrative expenses (552) (212) (231) (391) — (727) (2,113) Other segment items (1) 12 56 (28) 248 — (51) 237 EBIT 1,225 521 118 465 — 2,329 (796) 1,533 Total depreciation, depletion and amortization (265) (125) (110) (176) — (676) (27) (703) Income (loss) from affiliates 22 (5) — 11 — 28 (2) 26 Total assets 16,345 7,649 3,805 14,104 — 41,903 2,625 44,528 Capital expenditures 790 108 611 183 — 1,692 31 1,723 As of, and for the year ended, December 31, 2024 (US$ in millions) Soybean Processing and Refining Softseed Processing and Refining Other Oilseeds Processing and Refining Grain Merchandising and Milling Eliminations Total Reportable Segments Corporate & Other Total Bunge Consolidated Net sales to external customers $ 31,930 $ 6,951 $ 4,151 $ 10,073 $ — $ 53,105 $ 3 $ 53,108 Inter–segment revenues 824 918 334 1,568 (3,644) — — Raw materials cost (29,030) (5,559) (3,151) (9,075) — (2) (46,817) Industrial expenses- fixed (847) (286) (268) (268) — (7) (1,676) Industrial expenses- variable (453) (174) (110) (53) — — (790) Depreciation (186) (78) (84) (62) — (22) (432) Selling, general and administrative expenses (465) (146) (254) (261) — (650) (1,776) Other segment items (1) (77) (45) (68) 54 — 311 175 EBIT 872 663 216 408 — 2,159 (367) 1,792 Depreciation, depletion and amortization (187) (78) (116) (65) — (446) (22) (468) (Loss) income from affiliates (51) — 1 (7) — (57) 19 (38) Total assets 10,109 2,638 3,182 4,483 — 20,412 4,487 24,899 Capital expenditures 632 111 454 144 — 1,341 35 1,376 F-72 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) As of, and for the year ended, December 31, 2023 (US$ in millions) Soybean Processing and Refining Softseed Processing and Refining Other Oilseeds Processing and Refining Grain Merchandising and Milling Eliminations Total Reportable Segments Corporate & Other Total Bunge Consolidated Net sales to external customers $ 36,147 $ 7,736 $ 4,237 $ 11,415 $ — $ 59,535 $ 5 $ 59,540 Inter–segment revenues 1,099 1,021 277 1,204 (3,601) — — Raw materials cost (31,907) (5,948) (3,380) (10,557) — 23 (51,769) Industrial expenses- fixed (844) (302) (250) (237) — (18) (1,651) Industrial expenses- variable (498) (206) (121) (57) — — (882) Depreciation (165) (70) (78) (59) — (21) (393) Selling, general and administrative expenses (452) (146) (278) (251) — (588) (1,715) Other segment items (1) (59) 10 (36) 47 — 241 203 EBIT 2,222 1,074 94 301 — 3,691 (358) 3,333 Depreciation, depletion and amortization (165) (71) (133) (61) — (430) (21) (451) (Loss) income from affiliates (9) 2 (17) 7 — (17) 157 140 Total assets 11,310 2,681 2,711 4,437 — 21,139 4,233 25,372 Capital expenditures 423 142 411 121 — 1,097 25 1,122 (1) Other segment items for each reportable segment includes Foreign exchange (losses) gains – net, Other income – net, Income (loss) from affiliates, and EBIT – Noncontrolling interests, which includes Net income attributable to noncontrolling interests and redeemable noncontrolling interests adjusted for noncontrolling interests' share of interest and taxes.
The resulting exchange gain or loss is included in Bunge's consolidated statements of income as Foreign exchange gains (losses) - net unless the remeasurement gain or loss relates to an intercompany transaction that is of a long-term investment nature and for which settlement is neither planned nor anticipated in the foreseeable future, in which case the remeasurement gain or loss is reported as a component of Accumulated other comprehensive loss in Bunge's consolidated balance sheets.
The resulting exchange gain or loss is included in Bunge's consolidated statements of income as Foreign exchange (losses) gains — net unless the remeasurement gain or loss relates to an intercompany transaction that is of a long-term investment nature and for which settlement is neither planned nor anticipated in the foreseeable future, in which case the remeasurement gain or loss is reported as a component of Accumulated other comprehensive loss in Bunge's consolidated balance sheets.
Under this guidance, a class of receivables is considered impaired, based on current information and events, if Bunge determines it probable that all amounts due under the original terms of the receivable will not be collected.
Under this guidance, a class of receivables is considered impaired, based on current information and events, if Bunge determines it is probable that all amounts due under the original terms of the receivable will not be collected.
Senior Notes - On September 17, 2024, Bunge completed the sale and issuance of (i) $400 million aggregate principal amount of 4.100% senior notes due 2028, (ii) $800 million aggregate principal amount of 4.200% senior notes due 2029, and (iii) $800 million aggregate principal amount of 4.650% senior notes due 2034.
Senior Notes - On September 17, 2024, Bunge completed the sale and issuance of (i) $400 million aggregate principal amount of 4.100% senior notes due 2028, (ii) $800 million aggregate principal amount of 4.200% senior notes due 2029, and (iii) $800 million aggregate principal amount of 4.650% senior notes due 2034 ("Senior Notes").
Plan Settlements — On June 30, 2023, the Company approved a one-time lump sum offering to participants in certain of Bunge's defined benefit North American pension plans who had separated from the Company as of December 31, 2022 and whose benefits in the plan had fully vested. The respective payments were substantially completed during September 2023.
On June 30, 2023, the Company approved a one-time lump sum offering to participants in certain of Bunge's defined benefit North American pension plans who had separated from the Company as of December 31, 2022 and whose benefits in the plan had fully vested. The respective payments were substantially completed during September 2023.
Indemnitie s—Bunge has issued or was a party to the following indemnities at December 31, 2024: On October 1, 2024, Bunge agreed to indemnify the buyer in relation to the sale of its ownership interest in BP Bunge Bioenergia against future losses associated with certain legal claims as defined in the share purchase agreement.
Indemnitie s—Bunge has issued or was a party to the following indemnities at December 31, 2025: On October 1, 2024, Bunge agreed to indemnify the buyer in relation to the sale of its ownership interest in BP Bunge Bioenergia against future losses associated with certain legal claims as defined in the share purchase agreement.
The Program includes sustainability provisions, pursuant to which the applicable margin will be increased or decreased based on Bunge's performance relative to certain sustainability targets, including, but not limited to, science-based targets ("SBTs") that define Bunge's climate goals within its operations and a commitment to a deforestation-free supply chain in 2025.
The Program includes sustainability provisions, pursuant to which the applicable margin will be increased or decreased based on Bunge's performance relative to certain sustainability targets, including, but not limited to, science-based targets that define Bunge's climate goals within its operations and a commitment to a deforestation-free supply chain in 2025.
(3) The year ended December 31, 2023 included the release of cumulative translation adjustments upon the disposition of all of its Russian operations of $103 million, which had been previously reserved through Cost of goods sold, in the consolidated statements of income in the year ended December 31, 2022 (see Note 2- Acquisitions and Dispositions ).
(2) The year ended December 31, 2023 included the release of cumulative translation adjustments upon the disposition of all of its Russian operations of $103 million, which had been previously reserved through Cost of goods sold, in the consolidated statements of income in the year ended December 31, 2022 (see Note 2- Acquisitions and Dispositions ).
The Program provides for funding of up to $1.5 billion and from time to time with the consent of the administrative agent, Bunge may request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments by an amount not to exceed $1 billion pursuant to an accordion provision.
The Program provides for funding of up to $1.5 billion and from time to time with the consent of the administrative agent, Bunge may request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments by an amount not to exceed $1 billion pursuant to an accordion provision under the Program.
The payments, which were paid from plan assets as settlement of respective benefit obligations, resulted in a $22 million decrease in benefit obligations and the reclassification of an unamortized gain of less than $1 million from Accumulated other comprehensive loss, which was recorded in Other income (expense) - net on the consolidated statements of income.
The payments, which were paid from plan assets as settlement of respective benefit obligations, resulted in a $22 million decrease in benefit obligations and the reclassification of an unamortized gain of less than $1 million from Accumulated other comprehensive loss, which was recorded in Other income - net on the consolidated statements of income.
Inventories —Readily marketable inventories ("RMI") are agricultural commodity inventories, primarily including soybeans, soybean meal, soybean oil, corn, softseeds and wheat that are readily convertible to cash because of their commodity characteristics, widely available markets, and international pricing mechanisms. All of Bunge's RMI are recorded at fair value.
Inventories —Readily marketable inventories ("RMI") are agricultural commodity inventories, primarily including soybeans, soybean meal, soybean oil, corn, softseeds, softseed oil, and wheat that are readily convertible to cash because of their commodity characteristics, widely available markets, and international pricing mechanisms. All of Bunge's RMI are recorded at fair value.
The Company uses derivative instruments referred to as forward freight agreements ("FFA") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold. The Company uses energy derivative instruments to manage its exposure to volatility in energy costs.
The Company uses derivative instruments referred to as forward freight agreements ("FFAs") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold. The Company uses energy derivative instruments to manage its exposure to volatility in energy costs.
The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives to manage exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives to manage its exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
Share Repurchase Program — On November 13, 2024, Bunge Global SA's Board approved the expansion of an existing share repurchase program by an additional $500 million bringing total authorizations under the program since inception to $2.7 billion. The program continues to have an indefinite term.
Share Repurchase Program — On November 13, 2024, Bunge Global SA's Board of Directors approved the expansion of an existing share repurchase program by an additional $500 million bringing total authorizations under the program since inception to $2.7 billion. The program continues to have an indefinite term.
Leases with an initial term of more than 12 months are recognized on the balance sheet as right-of-use assets (Operating lease assets) and lease liabilities for the obligation to make payments under such leases (Current operating lease obligations and Non-current operating lease obligations).
Leases with an initial term of more than 12 months are recognized on the consolidated balance sheet as right-of-use assets (Operating lease assets) and lease liabilities for the obligation to make payments under such leases (Current operating lease obligations and Non-current operating lease obligations).
Bunge considers various factors in determining whether to recognize an impairment charge, including the length of time the fair value of the investment is expected to be below its carrying value, the financial condition, operating performance and near-term prospects of the affiliate, and Bunge's intent and ability to hold the F-16 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) investment for a period of time sufficient to allow for recovery of the fair value (see Note 10- Impairments and Note 11- Investments in Affiliates and Variable Interest Entities ).
Bunge considers various factors in determining whether to recognize an impairment charge, including the length of time the fair value of the investment is expected to be below its carrying value, the financial condition, operating performance and near-term prospects of the affiliate, and Bunge's intent and ability to hold the F-17 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) investment for a period of time sufficient to allow for recovery of the fair value (see Note 10- Impairments and Note 11- Investments in Affiliates and Variable Interest Entities ).
Service cost is included in the same income statement line item as other compensation costs arising from services rendered during the period, while the other components of net periodic benefit pension cost are presented separately in Other (expense) income- net.
Service cost is included in the same income statement line item as other compensation costs arising from services rendered during the period, while the other components of net periodic benefit pension cost are presented separately in Other income- net.
For the year ended December 31, 2023, Net income attributable to Bunge included $12 million of expense (net of $5 million in tax benefit) and Net income attributable to noncontrolling interests and redeemable noncontrolling interests included $3 million of expense (net of $1 million in tax benefit) related to accelerated amortization. 10.
For the year ended December 31, 2023, Net income attributable to Bunge included $12 million of expense (net of $5 million in tax benefit) and Net income attributable to noncontrolling interests and redeemable noncontrolling interests included $3 million of expense (net of $1 million in tax benefit) related to accelerated amortization.
The transaction close resulted in a pretax gain on sale of $195 million, which was recorded within Other income (expense) - net, in the consolidated statement of income for the year ended December 31, 2024.
The transaction close resulted in a pretax gain on sale of $195 million, which was recorded within Other income - net, in the consolidated statement of income for the year ended December 31, 2024.
As further described in Note 1- Nature of Business, Basis of Presentation and Significant Accounting Policies , the Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging (ASC 815) and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts F-69 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) with Customers (ASC 606).
As further described in Note 1- Nature of Business, Basis of Presentation and Significant Accounting Policies , the Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, Derivatives and Hedging (ASC 815) and sales of other products and services that are accounted for under ASC 606, Revenue from Contracts F-74 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) with Customers (ASC 606).
F-14 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) Level 2 Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
F-15 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) Level 2 Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Performance of that analysis requires the exercise of judgment. The primary beneficiary analysis must be continually reassessed and requires the exercise of judgement. VIE assessments are revisited upon the occurrence of relevant reconsideration events.
Performance of that analysis requires the exercise of judgment. The primary beneficiary analysis must be continually reassessed and requires the exercise of judgment. VIE assessments are revisited upon the occurrence of relevant reconsideration events.
The Company’s CODM is the chief executive officer. Total reportable segment earnings before interest and taxes ("EBIT") is the key operating performance measure utilized by the CODM to evaluate reportable segment operating activities and performance.
The Company’s CODM is the chief executive officer. Reportable segment earnings before interest and taxes ("EBIT") is the key operating performance measure utilized by the CODM to evaluate reportable segment operating activities and performance.
Debt F-15 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) trading securities and all equity securities are recorded at fair value and are bought and held principally for selling them in the near term and therefore held for only a short period of time, with all gains (losses) included in Net income.
Debt F-16 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) trading securities and all equity securities are recorded at fair value and are bought and held principally for selling them in the near term and therefore held for only a short period of time, with all gains (losses) included in Net income.
In connection with the transaction, Bunge has agreed to indemnify BP against future losses associated with certain legal claims as defined in the share purchase agreement . As a consequence, Bunge recognized a liability of $95 million in accordance with ASC 460, Guarantees and ASC 450, Contingencies . See Note 20- Commitments and Contingencies for more information.
In connection with the transaction, Bunge has agreed to indemnify BP against future losses associated with certain legal claims as defined in the share purchase agreement. As a consequence, Bunge recognized a liability of $95 million upon transaction close in accordance with ASC 460, Guarantees and ASC 450, Contingencies . See Note 20- Commitments and Contingencies for more information.
Non-cancelable subleases primarily relate to agreements with third parties for the use of portions of certain facilities with remaining sublease terms of up to five years. Additionally, from time to time, the Company may enter into re-let agreements to sell the right to use ocean freight vessels under time charter agreements when excess capacity is available.
Non-cancelable subleases primarily relate to agreements with third parties for the use of portions of certain facilities with remaining sublease terms of up to ten years. Additionally, from time to time, the Company may enter into re-let agreements to sell the right to use ocean freight vessels under time charter agreements when excess capacity is available.
The following table presents the values of the assets and liabilities associated with the above listed VIEs in which Bunge is considered the primary beneficiary to the extent included in Bunge’s consolidated balance sheet as of December 31, 2024 and 2023. All amounts exclude intercompany balances, which have been eliminated upon consolidation.
The following table presents the values of the assets and liabilities associated with the above listed VIEs in which Bunge is considered the primary beneficiary to the extent included in Bunge’s consolidated balance sheet as of December 31, 2025 and 2024. All amounts exclude intercompany balances, which have been eliminated upon consolidation.
(2) Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2025 through 2029.
(2) Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2026 through 2029.
At December 31, 2024, and December 31, 2023, Bunge recognized a $12 million and $13 million reduction to Other current liabilities, respectively, in the consolidated balance sheets related to benefits not yet realized. Clean energy —Bunge receives cash grants from a governmental agency from the sale of clean energy.
At December 31, 2025, and December 31, 2024, Bunge recognized a $13 million and $12 million reduction to Other current liabilities, respectively, in the consolidated balance sheets related to benefits not yet realized. Clean energy —Bunge receives cash grants from a governmental agency from the sale of clean energy.
As of December 31, 2024, the Brazilian federal and state authorities have concluded examinations of the ICMS and PIS/COFINS tax returns and have issued outstanding claims. The Company continues to evaluate the merits of each of these claims and will recognize them if and when loss is considered probable.
As of December 31, 2025, the Brazilian federal and state authorities have concluded examinations of the ICMS and PIS/COFINS tax returns and have issued outstanding claims. The Company continues to evaluate the merits of each of these claims and will recognize them if and when loss is considered probable.
Bunge also retains ownership of a population of unsold receivables. BSBV agrees to guaranty the collection of sold receivables and grants a lien to the administrative agent on all unsold receivables. Collections on unsold receivables and guarantee payments are classified as operating activities in Bunge’s consolidated statements of cash flows.
BSBV also retains ownership of a population of unsold receivables. BSBV agrees to guarantee the collection of sold receivables and grants a lien to the administrative agent on all unsold receivables. Collections on unsold receivables and guarantee payments are classified as operating activities in Bunge’s consolidated statements of cash flows.
Year Ended December 31, 2024 (US$ in millions) Readily Marketable Inventories (2) Derivatives, Net Trade Accounts Payable Total Balance, January 1, 2024 $ 662 $ 71 $ (232) $ 501 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 645 (59) 15 601 Purchases 1,704 — (444) 1,260 Sales (2,341) — — (2,341) Settlements — — 607 607 Transfers into Level 3 1,507 26 (238) 1,295 Transfers out of Level 3 (1,576) (6) 156 (1,426) Translation adjustment (182) (2) 74 (110) Balance, December 31, 2024 $ 419 $ 30 $ (62) $ 387 (1) Readily marketa ble inventori es, derivatives, net, and trade accounts payable include gains/(losses) of $591 million, $(42) million, and $11 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at December 31, 2024.
Year Ended December 31, 2024 (US$ in millions) Readily Marketable Inventories Derivatives, Net Trade Accounts Payable Total Balance, January 1, 2024 $ 662 $ 71 $ (232) $ 501 Total gains and losses (realized/unrealized) included in Cost of goods sold (1) 645 (59) 15 601 Purchases 1,704 — (444) 1,260 Sales (2,341) — — (2,341) Settlements — — 607 607 Transfers into Level 3 1,507 26 (238) 1,295 Transfers out of Level 3 (1,576) (6) 156 (1,426) Translation Adjustment (182) (2) 74 (110) Balance, December 31, 2024 $ 419 $ 30 $ (62) $ 387 (1) Readily marketable inventories, derivatives, net, and trade accounts payable, include gains/(losses) of $591 million, $(42) million, and $11 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at December 31, 2024. 16.
The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company's consolidated balance sheets as of December 31, 2024, and 2023 are included in Note 16- Derivative Instruments and Hedging Activities .
The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company's consolidated balance sheets as of December 31, 2025, and 2024 are included in Note 16- Derivative Instruments and Hedging Activities .
The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the years ended December 31, 2024, 2023, and 2022. 4.
The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the years ended December 31, 2025, 2024, and 2023. 4.
However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period the uncertainties are resolved should the liability substantially exceed the F-56 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) amount of provisions included in the consolidated balance sheets.
However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period in which the uncertainties are resolved F-61 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) should the liability substantially exceed the amount of provisions included in the consolidated balance sheets.
Concurrently with the US Exchange Offers, BLFC successfully solicited consents, on behalf of VFBV, and VFBV amended the respective indentures governing the Existing USD Viterra Notes on September 23, 2024 to, among other things, eliminate certain of the covenants, restrictive provisions and events of default, and modify or amend certain other provisions, including unconditionally releasing and discharging the guarantees by each of Viterra and Viterra B.V.
Concurrently with the US Exchange Offers, BLFC successfully solicited consents, on behalf of VFBV, and VFBV amended the respective indentures governing the Existing USD Viterra Notes to, among other things, eliminate certain of the covenants, restrictive provisions and events of default, and modify or amend certain other provisions, including unconditionally releasing and discharging the guarantees by each of Viterra and Viterra B.V.
The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees.
The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2041. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees.
Critical estimates in the determination of fair value under the income approach include, but are not limited to, assumptions about variables such as commodity prices, crop and related throughput and production volumes, profitability, future capital expenditures, other expenses, and discount rates, all of which are subject to a high degree of judgment.
Critical estimates in the determination of fair value under the income approach include, but are not limited to, assumptions about variables such as commodity prices, crop and related throughput and production volumes, gross profit, future capital expenditures, other expenses, and discount rates, all of which are subject to a high degree of judgment.
At both December 31, 2024 and 2023, Bunge has recognized a $9 million obligation related to this indemnity within Other non-current liabilities and has maximum potential future payments of $235 million.
At both December 31, 2025 and 2024, Bunge has recognized a $9 million obligation related to this indemnity within Other non-current liabilities and has maximum potential future payments of $235 million.
As a result, the sum of the quarterly earnings per share for the years ended December 31, 2024 and 2023 may not equal the total computed for the year. See Note 23- Earnings per Share for further details.
As a result, the sum of the quarterly earnings per share for the years ended December 31, 2025 and 2024 may not equal the total computed for the year. See Note 23- Earnings per Share for further details.
Restrictions on TBRSUs are based on continued service by the recipient through the designated term. Restrictions on PBRSUs are based on the achievement of certain performance targets, including earnings per share, return on invested capital, and relative total shareholder return, with the number of PBRSUs earned varying based on the level of achievement against these performance targets.
Restrictions on TBRSUs and PBRSUs are based on continued service by the recipient through the designated term. In addition, PBRSUs have restrictions based on the achievement of certain performance targets, including earnings per share, return on invested capital, and relative total shareholder return, with the number of PBRSUs earned varying based on the level of achievement against these performance targets.
Cash, Cash Equivalents, Restricted Cash, and Cash held for sale —Cash and cash equivalents include time deposits and readily marketable securities with original maturity dates of three months or less at the time of acquisition. Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.
Cash, Cash Equivalents, and Restricted Cash —Cash and cash equivalents include time deposits and readily marketable securities with original maturity dates of three months or less at the time of acquisition. Restricted cash is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.
CJ Latam and Selecta Share Purchase Agreement On October 10, 2023, Bunge entered into a definitive share purchase agreement with CJ CheilJedang Corporation and STIC CJ Global Investment Corporate Partnership Private Equity Fund to acquire 100% of outstanding equity of CJ Latam Participações Ltda. and CJ Selecta S.A.
CJ Latam and Selecta Share Purchase Agreement On October 10, 2023, Bunge entered into a definitive share purchase agreement with CJ CheilJedang Corporation and STIC CJ Global Investment Corporate Partnership Private Equity Fund (collectively, "CJ") to acquire 100% of outstanding equity of CJ Latam Participações Ltda. and CJ Selecta S.A. (collectively, “CJ Selecta”).
Bunge is the primary beneficiary due to a de facto agent relationship with the equity owner of TGSC and has consolidated the entity since the third quarter of 2023.
Bunge was the primary beneficiary due to a de facto agent relationship with the equity owner of TGSC and has consolidated the entity since the third quarter of 2023.
Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current liabilities, including any unrealized gain or loss on changes in SOFR is not significant as of December 31, 2024, and 2023.
Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current assets, or Other current liabilities, including any unrealized gain or loss on changes in SOFR, is not significant as of December 31, 2025, and 2024.
Recoverable Taxes —Recoverable taxes include value-added taxes paid upon the acquisition of raw materials and taxable services and other transactional taxes, which can be recovered in cash or as compensation against income taxes or other taxes owed by Bunge, primarily in Brazil and Europe.
Recoverable Taxes —Recoverable taxes include value-added taxes paid upon the acquisition of raw materials and taxable services and other transactional taxes, which can be recovered in cash or as compensation against income taxes or other taxes owed by Bunge, primarily in South America and Europe.
Dividends on registered shares —We paid cash dividends to shareholders as follows: Year Ended December 31, 2024 2023 2022 Dividends paid per share $ 2.7025 $ 2.575 $ 2.30 Dividend distributions occurring after the Redomestication are at the discretion of the Board of Directors and the approval of shareholders at a general meeting in accordance with Swiss law.
Dividends on registered shares —We paid cash dividends to shareholders as follows: Year Ended December 31, 2025 2024 2023 Dividends paid per share $ 2.78 $ 2.7025 $ 2.575 Dividend distributions occurring after the Redomestication are at the discretion of the Board of Directors and the approval of shareholders at a general meeting in accordance with Swiss law.
Interest earned on secured advances to suppliers of $25 million , $25 million, and $22 million, for the years ended December 31, 2024, 2023, and 2022, respectively, is included in Net sales in the consolidated statements of income. (3) Marketable securities and other short-term investments—Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities.
Interest earned on secured advances to suppliers of $28 million, $25 million, and $25 million, for the years ended December 31, 2025, 2024, and 2023, respectively, is included in Net sales in the consolidated statements of income. (3) Marketable securities and other short-term investments—Bunge invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities.
The program is valid through 2032 and contains recapture features if the Company does not follow program production efficiency requirements. For the years ended December 31, 2024, 2023, and 2022, Bunge recorded program related cash grants of $23 million, $24 million and $19 million in Cost of goods sold in the consolidated statements of income, respectively.
The program is valid through 2032 and contains recapture features if the Company does not follow program production efficiency requirements. For the years ended December 31, 2025, 2024, and 2023, Bunge recorded program related cash grants of $14 million, $23 million and $24 million in Cost of goods sold in the consolidated statements of income, respectively.
Neppl Executive Vice President and Chief Financial Officer S-1 Table of Contents Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. February 20, 2025 By: /s/ GREGORY A. HECKMAN Gregory A.
Neppl Executive Vice President and Chief Financial Officer S-1 Table of Contents Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. February 19, 2026 By: /s/ GREGORY A. HECKMAN Gregory A.
At December 31, 2024, F-57 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) no obligation has been recorded related to these guarantees. Any obligation recorded would be re cognized in Current operating lease obligations or Non-current operating lease obligations.
At December 31, 2025, F-62 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) no obligation has been recorded related to these guarantees. Any obligation recorded would be re cognized in Current operating lease obligations or Non-current operating lease obligations.
Includes principal maturities of long-term debt attributable to finance leases, see Note 25- Leases for a separate breakout of finance lease maturities. During the years ended December 31, 2024, 2023, and 2022, Bunge paid interest, net of interest capitalized, of $434 million, $507 million, and $403 million, respectively. 18.
Includes principal maturities of long-term debt attributable to finance leases, see Note 25- Leases for a separate breakout of finance lease maturities. During the years ended December 31, 2025, 2024, and 2023, Bunge paid interest, net of interest capitalized, of $562 million, $434 million, and $507 million, respectively. 18.
At December 31, 2024, Bunge's pre-tax loss carryforwards totaled $1.9 billion, of which $1.7 billion have no expiration, including loss carryforwards of $1.2 billion in Brazil. While loss carryforwards in Brazil can be carried forward indefinitely, annual utilization is limited to 30% of taxable income calculated on an entity-by-entity basis as Brazil tax law does not allow consolidated tax filings.
At December 31, 2025, Bunge's pre-tax loss carryforwards totaled $2.5 billion, of which $2.2 billion have no expiration, including loss carryforwards of $1.2 billion in Brazil. While loss carryforwards in Brazil can be carried forward indefinitely, annual utilization is limited to 30% of taxable income calculated on an entity-by-entity basis as Brazil tax law does not allow consolidated tax filings.
Collectively, the three tranches of Senior Notes total an aggregate principal amount of $2.0 billion. The Senior Notes are fully and unconditionally guaranteed by Bunge. The offering was made pursuant to a shelf registration statement on Form S-3 (Registration No. 333-282003) filed by the Company and its 100% owned finance subsidiary, BLFC, with the U.S. Securities and Exchange Commission.
Collectively, the three tranches of Senior Notes total an aggregate principal amount of $2.0 billion. The Senior Notes are fully and unconditionally guaranteed by Bunge. The offering was made pursuant to a shelf registration statement on Form S-3 (Registration No. 333-282003) filed by the Company and its 100% owned finance subsidiary, BLFC, with the SEC.
Corporate and Other, which is not a reportable segment, includes salaries and overhead for corporate functions that are not allocated to the Company’s individual reporting segments because the operating performance of such reporting segments is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance program, accounts receivable securitization activities, and certain income tax assets and liabilities.
Corporate and Other, which is not a reportable segment, includes salaries and overhead for corporate functions, including acquisition and integration costs related to the Viterra Acquisition, that are not allocated to the Company’s individual reporting segments because the operating performance of such reporting segments is evaluated by the Company's chief operating decision maker ("CODM") exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance program, accounts receivable securitization activities, and certain income tax assets and liabilities.
F-52 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) Pension Benefit Obligations and Funded Status—The following table sets forth in aggregate the changes in the defined benefit pension and postretirement benefit plans' benefit obligations, assets and funded status at December 31, 2024 and 2023.
F-57 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) Pension Benefit Obligations and Funded Status —The following table sets forth in aggregate the changes in the defined benefit pension and postretirement benefit plans' benefit obligations, assets and funded status at December 31, 2025 and 2024.
F-46 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) 17.
F-51 Table of Contents BUNGE GLOBAL SA AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued) 17.
These income tax prepayments are expected to be used for the settlement future income tax obligations. Income taxes receivable in Brazil bear interest at the Selic rate. Long-term investments —Long-term investments primarily comprise Bunge's noncontrolling equity investments in growth stage agribusiness and food companies held by Bunge Ventures.
These income tax prepayments are expected to be used for the settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the Selic rate. Long-term investments —Long-term investments primarily comprise Bunge's noncontrolling equity investments held by Bunge Ventures in growth stage companies and related investment funds in the agribusiness and food sectors.
For the years ended December 31, 2024, 2023, and 2022, net returns from these activities were $58 million, $36 million, and $32 million, respectively, and were included as a reduction of Cost of goods sold in the accompanying consolidated statements of income.
For the years ended December 31, 2025, 2024, and 2023, net returns from these activities were $46 million, $58 million, and $36 million, respectively, and were included as a reduction of Cost of goods sold in the accompanying consolidated statements of income.
The table below reflects the tax years for which Bunge is subject to income tax examinations by tax authorities in significant tax regions: Open Tax Years North America 2015 - 2024 South America 2017 - 2024 Europe, Middle East, and Africa 2017 - 2024 Asia-Pacific 2015 - 2024 As of December 31, 2024, Bunge's Brazilian subsidiaries have received income tax and penalty assessments through 2018 of approximately R$5.3 billion (approximately $856 million) plus applicable interest on the outstanding amount.
The table below reflects the tax years for which Bunge is subject to income tax examinations by tax authorities in significant tax regions: Open Tax Years North America 2016 - 2025 South America 2018 - 2025 Europe, Middle East, and Africa 2017 - 2025 Asia-Pacific 2015 - 2025 As of December 31, 2025, Bunge's Brazilian subsidiaries have received income tax and penalty assessments through 2018 of approximately R$4.3 billion (approximately $790 million) plus applicable interest on the outstanding amount.
Bunge has also entered into standby letters of credit and surety bonds with financial institutions primarily relating to the guarantee of our future performance on certain contracts. Amounts on outstanding standby letter of credit agreements and surety bonds aggregated to $1,610 million and $1,858 million as of December 31, 2024 and 2023, respectively. 21.
Bunge has also entered into standby letters of credit and surety bonds with financial institutions primarily relating to the guarantee of our future performance on certain contracts. Amounts on outstanding standby letter of credit agreements and surety bonds aggregated to $2,151 million and $1,610 million as of December 31, 2025 and 2024, respectively. 21.
During 2024, 2023 and 2022, respectively, Bunge recognized $2 million, less than $1 million and $(7) million of interest and penalty charges in Income tax expense in the consolidated statements of income.
During 2025, 2024 and 2023, respectively, Bunge recognized $(1) million, $2 million, and less than $1 million of interest and penalty charges in Income tax expense in the consolidated statements of income.
The Program will terminate on May 17, 2031; however, each committed purchaser's commitment to purchase trade receivables under the Program will terminate earlier on December 16, 2025, with a feature that permits Bunge to request 364-day extensions.
The Program will terminate on May 17, 2031; however, each committed purchaser's commitment to purchase trade receivables under the Program will terminate earlier on December 15, 2026, with a feature that permits Bunge to request 364-day extensions.
BCAR is a VIE in which Bunge is considered to be the primary beneficiary because it is responsible for the day-to-day operating decisions of BCAR as well as the marketing of the principal products, primarily soybean meal and oil produced and sold by BCAR, among other factors.
Further, Bunge Chevron Ag Renewables LLC ("BCAR") is a VIE in which Bunge is considered to be the primary beneficiary because it is responsible for the day-to-day operating decisions of BCAR as well as the marketing of the principal products, primarily soybean meal and oil produced and sold by BCAR, among other factors.
Recoverable taxes, net —Recoverable taxes are reported net of allowances of $9 million and $13 million at December 31, 2024 and 2023, respectively. Judicial deposits —Judicial deposits are funds that Bunge has placed on deposit with the courts in Brazil.
Recoverable taxes, net — Recoverable taxes are reported net of allowances of $6 million and $9 million at December 31, 2025 and 2024, respectively. Judicial deposits —Judicial deposits are funds that Bunge has placed on deposit with the courts in Brazil.
In other words, the earnings effect of an increase in the fair value of the derivative will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense.
In other words, the earnings effect of a change in the fair value of the derivative will be substantially offset by the earnings effect of the change in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense.
Other Short-term Debt In addition to the committed facilities discussed above, from time to time, Bunge Global SA and/or its financing subsidiaries may enter into uncommitted bilateral short-term credit lines as necessary based on its financing requirements. At December 31, 2024 and 2023, there were no borrowings outstanding under these bilateral short-term credit lines.
Other Short-term Debt In addition to the committed facilities discussed above, from time to time, Bunge Global SA and/or its financing subsidiaries may enter into uncommitted bilateral short-term credit lines as necessary based on its financing requirements. At December 31, 2025 there were $900 million borrowings outstanding, under these bilateral short-term credit lines.
F-71 Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BUNGE GLOBAL SA Dated: February 20, 2025 By: /s/ JOHN W. NEPPL John W.
F-76 Table of Contents SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BUNGE GLOBAL SA Dated: February 19, 2026 By: /s/ JOHN W. NEPPL John W.
The outstanding claims comprise the following: December 31, (US$ in millions) Years Examined 2024 2023 ICMS 1990 to Present $ 128 $ 212 PIS/COFINS 2002 to Present $ 427 $ 438 Labor claims — The labor claims are principally against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits.
The outstanding claims comprise the following: December 31, (US$ in millions) Years Examined 2025 2024 ICMS 1990 to Present $ 155 $ 128 PIS/COFINS 2002 to Present $ 490 $ 427 Labor claims — The labor claims are principally against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits.
At December 31, 2023, an 8.8% annual rate of increase in the per capita cost of covered healthcare benefits was assumed for 2023 postretirement benefit plan measurement purposes, decreasing to 8.2% by 2048, and remaining at that level thereafter.
At December 31, 2024, an 8.5% annual rate of increase in the per capita cost of covered healthcare benefits was assumed for 2024 postretirement benefit plan measurement purposes, decreasing to 8.1% by 2048, and remaining at that level thereafter.
December 31, (US$ in millions) 2024 2023 Receivables sold which were derecognized from Bunge's balance sheet $ 1,148 $ 1,230 Receivables pledged to the administrative agent and included in Trade accounts receivable $ 123 $ 343 Bunge's risk of loss following the sale of trade receivables is limited to the assets of BSBV, primarily comprised of unsold receivables pledged to the administrative agent.
December 31, (US$ in millions) 2025 2024 Receivables sold which were derecognized from Bunge's balance sheet $ 1,174 $ 1,148 Receivables pledged to the administrative agent and included in Trade accounts receivable $ 182 $ 123 Bunge's risk of loss following the sale of trade receivables is limited to the assets of BSBV, primarily comprised of unsold receivables pledged to the administrative agent.
At December 31, 2024, and 2023, the unpaid portion of the dividends accrued in Other current liabilities on the consolidated balance sheets totaled $91 million and $96 million, respectively, see Note 13- Other Current Liabilities .
At December 31, 2025, and 2024, the unpaid portion of the dividends accrued in Other current liabilities on the consolidated balance sheets totaled $135 million and $91 million, respectively, see Note 13- Other Current Liabilities .
Revenue from contracts with customers (ASC 606) —Revenue from contracts with customers accounted for under ASC 606 is primarily generated in the Company's Refined and Specialty Oils and Milling segments through the sale of refined edible oil-based products such as packaged vegetable oils, shortenings, margarines, and mayonnaise; milled grain products such as wheat flours, bakery mixes, and corn-based products; and fertilizer products.
Revenue from contracts with customers (ASC 606) —Revenue from contracts with customers accounted for under ASC 606 is primarily generated through the sale of refined edible oil-based products such as packaged vegetable oils, shortenings, margarines, and mayonnaise; milled grain products such as wheat flours and bakery mixes; and fertilizer products.
The following table provides a reconciliation of cash, cash equivalents, restricted cash, and cash and cash equivalents in Assets held for sale reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same such amounts shown in the consolidated statements of cash flows.
For the years ended December 31, 2024, 2023, and 2022, Bunge recorded program tax credits of $129 million, $176 million and $205 million in Net sales in the consolidated statements of income, respectively.
For the years ended December 31, 2025, 2024, and 2023, Bunge recorded program tax credits of $146 million, $129 million and $176 million in Net sales in the consolidated statements of income, respectively.
Borrowings under the $2 Billion Commercial Paper Program typically have an original maturity of three months or less, resulting in net presentation of proceeds and repayments of short-term debt in the consolidated statements of cash flows.
The $3 Billion Commercial Paper Program has no maturity date. Borrowings under the $3 Billion Commercial Paper Program typically have an original maturity of three months or less, resulting in net presentation of proceeds and repayments of short-term debt in the consolidated statements of cash flows.
Federal tax rate 320 641 434 Adjustments to derive effective tax rate: Foreign earnings taxed at different statutory rates (10) 142 (75) Valuation allowances 21 (30) (21) Fiscal incentives (1) (13) (76) (65) Foreign exchange on monetary items 21 (5) 31 Tax rate changes — 18 12 Non-deductible expenses 62 40 51 Uncertain tax positions 15 20 (9) Inflation adjustments (84) (32) (61) Incremental tax on future distributions 5 25 30 State taxes 18 22 18 Impairment of Russian operations — — 25 Gain on BP Bunge Bioenergia disposal (44) — — Swiss tax credits, net (2) — (90) — Other 25 39 18 Income tax expense $ 336 $ 714 $ 388 (1) Fiscal incentives predominantly relate to investment incentives in Brazil that are exempt from Brazilian income tax.
Federal tax rate 320 641 Adjustments to derive effective tax rate: Foreign earnings taxed at different statutory rates (10) 142 Valuation allowances 21 (30) Fiscal incentives (1) (13) (76) Foreign exchange on monetary items 21 (5) Tax rate changes — 18 Non-deductible expenses 62 40 Uncertain tax positions 15 20 Inflation adjustments (84) (32) Incremental tax on future distributions 5 25 State taxes 18 22 Gain on BP Bunge Bioenergia disposal (44) — Swiss tax credits, net (2) — (90) Other 25 39 Income tax expense $ 336 $ 714 (1) Fiscal incentives predominantly relate to investment incentives in Brazil that are exempt from Brazilian income tax.
The following table summarizes information related to aggregated defined benefit pension plans with an accumulated benefit obligation in excess of plan assets: Pension Benefits December 31, (US$ in millions) 2024 2023 Projected benefit obligation $ (268) $ (713) Accumulated benefit obligation $ (252) $ (697) Fair value of plan assets $ 126 $ 564 Pension Benefit Plan Assets —The objective of the plans' trust funds is to sufficiently diversify plan assets to maintain a reasonable level of risk without imprudently sacrificing returns.
The following table summarizes information related to aggregated defined benefit pension plans with an accumulated benefit obligation in excess of plan assets: Pension Benefits December 31, (US$ in millions) 2025 2024 Projected benefit obligation $ (322) $ (268) Accumulated benefit obligation $ (307) $ (252) Fair value of plan assets $ 172 $ 126 Pension Benefit Plan Assets —The objective of the plans' trust funds is to sufficiently diversify plan assets to maintain a reasonable level of risk without imprudently sacrificing returns.
Basis differences represent differences between the cost of the investment and the underlying equity in net assets of the investment and are amortized over the lives of the related assets that gave rise to them. At December 31, 2024, the aggregate of all basis differences was a debit of $134 million, including $46 million of amortizable basis difference.
Basis differences represent differences between the cost of the investment and the underlying equity in net assets of the investment and are amortized over the lives of the related assets that gave rise to them. At December 31, 2025, the aggregate of all basis differences was a debit of $422 million, including $44 million of amortizable basis difference.
At December 31, 2024 and 2023, advances to unconsolidated investees comprised approximately 4% or less of total Other current assets and 6% or less of total Other non-current assets. Bunge believes all transaction values to be similar to those that would be conducted with third parties at arm's-length. 20.
At December 31, 2025 and 2024, advances to unconsolidated investees comprised approximately 3% or less of total Other current assets and 7% or less of total Other non-current assets. Bunge believes all transaction values to be similar to those that would be conducted with third parties at arm's-length. 20.